We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore the genetic factors behind prostate cancer. Learn about hereditary links, key genes like BRCA1/BRCA2, family history impact, and risk factors relevant to Indian men.

Prostate cancer is a significant health concern for men worldwide, and understanding its causes is crucial for early detection and prevention. While most prostate cancers are not directly inherited, a small percentage are linked to genetic mutations. This article delves into the hereditary aspects of prostate cancer, exploring the genes involved, risk factors, and what it means for men and their families, particularly for our readers in India.
The prostate is a small gland in the male reproductive system, located below the bladder and in front of the rectum. Prostate cancer occurs when cells in the prostate gland begin to grow uncontrollably, forming a tumor. It is the most common cancer among men, with approximately 1 in 8 men receiving a diagnosis in their lifetime. Early stages often show no symptoms, making regular check-ups vital.
While lifestyle and environmental factors play a role, genetics can also contribute to prostate cancer risk. In most cases (around 95%), prostate cancer is sporadic, meaning it occurs due to random genetic mutations that happen during a person's lifetime, rather than being inherited. However, in about 5% to 10% of cases, prostate cancer can be hereditary, passed down through families via inherited gene mutations.
Estimating the exact percentage of hereditary prostate cancer can vary based on how it's defined. One common definition, known as the Hopkins Criteria, classifies prostate cancer as hereditary if:
Using these criteria, it's estimated that about 3% to 5% of all prostate cancers are considered hereditary.
Several gene mutations have been identified that can increase the risk of developing hereditary prostate cancer. The most well-known include:
Mutations in the BRCA1 and BRCA2 genes are strongly associated with an increased risk of several cancers, including prostate cancer. These genes are normally involved in repairing damaged DNA. When they are mutated, DNA repair is less efficient, leading to a higher chance of cells developing cancerous mutations. While these mutations are found in about 1 in 400 people in the general population, they are more common in individuals of Ashkenazi Jewish ancestry (about 1 in 40 people).
Men with BRCA2 mutations, in particular, may have a significantly higher risk of developing prostate cancer, potentially 2 to 10 times higher than those without the mutation. These mutations can also lead to more aggressive forms of prostate cancer and a higher likelihood of recurrence after treatment.
Mutations in the HOXB13 gene have also been linked to an increased risk of prostate cancer. This gene plays a role in prostate development. Certain mutations in HOXB13 are particularly common in families with a history of early-onset prostate cancer.
Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is another inherited condition that increases the risk of several cancers. While primarily known for colorectal and endometrial cancers, it also raises the risk of prostate cancer, especially before the age of 50.
A strong family history of prostate cancer is a significant indicator of potential hereditary risk. According to the American Cancer Society, having a brother or father with prostate cancer can more than double your risk. The risk is even higher if:
It's important to note that most men diagnosed with prostate cancer do not have a known family history. However, if you have a concerning family history, it's essential to discuss it with your doctor.
It's worth noting that mutations in BRCA1 and BRCA2 are not solely linked to prostate cancer. They also increase the risk of other cancers, including:
Besides genetics, several other factors can influence your risk of developing prostate cancer:
The risk of prostate cancer increases significantly with age. Most cases are diagnosed in men over the age of 65.
In India, as in many parts of the world, prostate cancer incidence varies among different ethnic groups. While specific data for India might differ, globally, African American men have a higher risk compared to other racial groups.
Some research suggests that diets high in dairy products or red meat might be associated with a slightly increased risk. Conversely, a diet rich in fruits, vegetables, and whole grains is generally considered protective.
While obesity may not significantly increase the overall risk of developing prostate cancer, some studies suggest it might be linked to a higher risk of advanced disease or dying from prostate cancer.
Certain occupational exposures, such as those faced by firefighters dealing with specific chemicals, have been linked to an increased risk of prostate cancer.
Diagnosing prostate cancer typically involves several steps:
For individuals with a strong family history of prostate cancer or other related cancers, genetic counseling and testing may be recommended. Genetic testing can identify specific mutations (like in BRCA1, BRCA2, or HOXB13) that increase cancer risk. This information can help in:
It's important to discuss the implications and benefits of genetic testing with a healthcare professional or genetic counselor.
You should consult a doctor if you experience any of the following:
Regular screening, particularly for men over 50 or those with higher risk factors, is crucial for early detection.
While you cannot change your genes, you can adopt lifestyle habits that may help reduce your risk or support overall health:
While not all cases can be prevented, adopting a healthy lifestyle and undergoing regular screenings can significantly reduce risk and aid in early detection, improving outcomes.
Not necessarily. Having a father with prostate cancer increases your risk, but it does not guarantee you will develop the disease. Many factors contribute to cancer development, and most men with a family history do not develop prostate cancer.
Genetic testing is typically recommended for individuals with a strong family history of prostate cancer or other related hereditary cancers, or those diagnosed at a young age. It is not a routine test for the general population but should be discussed with a doctor if you have concerns.
Yes. Genes like BRCA1 and BRCA2 are inherited from either parent. While these mutations increase cancer risk in men, they also increase cancer risk in women (e.g., breast, ovarian cancer). If a woman carries a mutation, she can pass it on to her sons, increasing their risk of prostate cancer.
Lynch syndrome increases the risk of several cancers, including prostate cancer, particularly in younger men. Individuals with Lynch syndrome should discuss comprehensive cancer screening with their doctor.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026